Redhill Biopharma
RDHL
Redhill Biopharma (RDHL) earnings history
Most recent quarter
- Fiscal period
- Q1 2023
- Period end
- Mar 31, 2023
- EPS actual
- −$1.25
- EPS estimate
- $0.00
- EPS surprise
- +0.00%
- Revenue surprise
- +0.00%
- Revenue
- $3.6M
- Revenue estimate
- $0.00
- Reported
- Jun 12, 2023
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q1 2023 | Jun 12, 2023 | $0.00 | −$1.25 | +0.00% | $3.6M | SEC |
| Q3 2022 | Nov 29, 2022 | −$10.00 | −$60.00 | −500.00% | $17.6M | — |
| Q2 2022 | Invalid Date | −$20.00 | −$20.00 | +0.00% | $18.3M | — |
| Q1 2022 | Jun 23, 2022 | −$300.00 | −$30.00 | +90.00% | $18.2M | — |
| Q4 2021 | Mar 17, 2022 | −$433.33 | −$500.00 | −15.38% | $22.1M | — |
| Q3 2021 | Nov 30, 2021 | −$474.29 | −$500.00 | −5.42% | $21.6M | — |
| Q2 2021 | Aug 26, 2021 | −$352.86 | −$600.00 | −70.04% | $21.5M | — |
| Q1 2021 | May 27, 2021 | −$435.00 | −$500.00 | −14.94% | $20.6M | — |
| Q4 2020 | Mar 18, 2021 | −$346.00 | −$650.00 | −87.86% | $21.5M | — |
| Q3 2020 | Nov 12, 2020 | −$270.00 | −$500.00 | −85.19% | $20.9M | — |
| Q2 2020 | Aug 13, 2020 | −$137.50 | −$400.00 | −190.91% | $20.9M | — |
| Q1 2020 | May 27, 2020 | −$690.00 | −$500.00 | +27.54% | $1.1M | — |
Quarterly revenue
Frequently asked questions
When did Redhill Biopharma (RDHL) last report earnings?
Redhill Biopharma last reported on Jun 12, 2023, covering fiscal Q1 2023.
Did RDHL beat earnings estimates?
Redhill Biopharma reported EPS of −$1.25 for Q1 2023, in line with the $0.00 consensus estimate.
How much revenue did RDHL report last quarter?
Redhill Biopharma reported $3.6M in revenue for Q1 2023.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.
